Experimental cancer drug trial halted early
NCT ID NCT06540066
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new antibody drug (BGB-B3227) alone or with another drug (tislelizumab) in 35 people with advanced solid tumors. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Zhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality, 200032, China
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
-
Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, 20133, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli
Roma, 00168, Italy
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601-1915, United States
-
Istituto Clinico Humanitas
Rozzano, 20089, Italy
-
Istituto Europeo Di Oncologia
Milan, 20141, Italy
-
Md Anderson Cancer Center
Houston, Texas, 77030-3907, United States
-
Next Oncology
Austin, Texas, 78758, United States
-
Usc Norris Comprehensive Cancer Center (Nccc)
Los Angeles, California, 90089-1019, United States
-
Washington University in St Louis
St Louis, Missouri, 63110-1010, United States